The aim of the study was to test the antiviral efficacy of a triple nucleoside reverse transcriptase inhibitor ( NRTI ) regimen , with potential beneficial metabolic effects , as maintenance therapy after induction with dual NRTIs and a boosted protease inhibitor ( PI ) .